Pleasanton, CA 6/26/14—Roche has made a strategic investment in Stratos Genomics and will collaborate with the company on research related to Stratos’s chemistry for single-molecule sequencing of DNA fragments using protein nanopores. The companies will work to develop efficient, low-cost sample preparation methods for DNA Xpandomers, a larger surrogate molecule, and to improve sequencing performance. […]

Company Announcements Andor Technology, an Oxford Instruments company, appointed Gary Wilmot, director of Engineering, as managing director in March. He replaces Conor Walsh. Hitachi High-Technologies announced in April the establishment of a Mexican subsidiary to accelerate business development in the automotive and industrial markets. In April, EMD Millipore announced a new, nonexclusive preferred-distribution agreement for […]

First quarter Life Science Index sales grew 5.0%, 7.1% on a currency-neutral basis, to $3,387 million. Index sales were driven by double-digit organic revenue growth each for Illumina, Fluidigm, BD Biosciences and Biotage. Operating profit climbed 11.0% to $719 million. Based on current operations, operating margin expanded 90 basis points to 19.4% of sales. Of […]

Basel, Germany 6/2/14—Roche has acquired Genia Technologies, a developer of single-molecule DNA-sequencing technology, for $125 million in cash and up to $225 million in contingent payments. Genia’s platform employs semiconductor-based nanopore technology and is expected to reduce the price of sequencing. The platform allows for electrical real-time analysis without the need for complicated optics, labels, […]

With the exception of several younger companies, the majority of analytical instrument and lab product companies in the table on page 4 recorded modest sales-per-employee growth in fiscal year 2013 (FY13). The average sales-per-employee ratio for the 18 companies grew 3.6% excluding currency to $319,284 in FY13. However, due to increased investments, acquisitions or slow […]